Press release
COVID-19 Saliva-Based Detection Kits Market to reach US$ 1.2 Bn by 2031 | Thermo Fisher Scientific Inc; Qiagen; Hologic; Takara Bio In
Browse for Full Report: https://www.factmr.com/report/covid-19-saliva-based-detection-kits-market
Why Did the Market Grow in 2021?
The surge in COVID-19 cases, with over 96.8 million confirmed cases in the U.S. alone by November 2022, fueled demand for saliva-based detection kits due to their non-invasive, patient-friendly nature. Saliva tests, like Yale's SalivaDirect authorized by the FDA in 2024, eliminated the need for nasopharyngeal swabs, reducing healthcare worker exposure by 10% and patient discomfort. Innovations such as Qiagen's 2021 CE-marked artus Prep&Amp test improved turnaround time by 15%. Government support, like the U.S.'s US$ 248.7 million NIH investment in diagnostics in 2020, boosted adoption, though declining cases and vaccination campaigns, covering 70% of the global population by 2024, temper future growth.
What Are the Key Market Projections?
The market, valued at US$ 1.6 billion in 2021, is expected to decline from US$ 1.4 billion in 2020 to US$ 1.2 billion by 2031, reflecting a -2.8% CAGR, resulting in a US$ -400 million opportunity loss. PCR-based kits, with a 73% share in 2021, are projected to maintain dominance due to their 95% sensitivity, though their share may decline to 70% by 2031 as rapid antigen tests gain traction. North America, holding a 91% share in the U.S. market in 2021, leads due to robust healthcare infrastructure, while Asia-Pacific grows at a 2.5% CAGR, driven by India's 909.9 million tests by 2022. Historical growth from 2019 to 2020 saw a 9.9% CAGR, but future declines are expected due to vaccination success.
How Can Stakeholders Leverage Opportunities?
Stakeholders in diagnostics and healthcare can focus on niche markets, such as saliva-based kits for detecting SARS-CoV-2 variants, like Thermo Fisher Scientific's 2021 acquisition of Mesa Biotech for rapid testing. Partnerships, such as Molbio Diagnostics' 2023 collaboration with Testi Technologies for saliva-based tests, enhance accessibility. Targeting Asia-Pacific, with India's growing self-testing market, and North America offers potential. Diagnostic labs and homecare, accounting for 26.8% and 10% of revenue in 2021, respectively, provide scalability. Compliance with FDA and CE standards ensures market trust, despite declining demand.
Want a Sample Before Buying? Download Free Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=6902
What Does the Report Cover?
Fact.MR's report combines primary research across 30+ countries and secondary analysis, covering segments by product (rapid test kits, PCR-based kits), technology (direct sample to PCR, RT-qPCR, lateral flow assay), application (COVID-19 diagnosis, research), end user (diagnostic labs, hospitals, clinics, academic institutes, homecare), and region (North America, Latin America, Europe, East Asia, South Asia & Oceania, Middle East & Africa). It highlights trends like at-home testing, cost-effective kits, and variant detection, providing actionable insights for stakeholders.
Who Are the Market Leaders?
Key players include Thermo Fisher Scientific Inc., Qiagen NV, ACON Laboratories Inc., Hologic Inc., and Zymo Research Corporation. Therma Bright Inc.'s 2021 CE-approved AcuVid rapid antigen test and Lenexa's 2020 FDA-approved saliva test strengthened portfolios. These companies, holding over 50% of the market, drive innovation through R&D and regulatory approvals, focusing on rapid, accurate diagnostics.
What Are the Latest Market Developments?
In 2024, saliva-based testing adoption grew by 10% in schools and workplaces due to its non-invasive nature. RT-qPCR technology, holding a 49.2% share in 2021, remains dominant for its accuracy. North America's 91% U.S. share reflects high testing rates, while Asia-Pacific's growth is driven by India's Angcard saliva test launch in 2021. Regulatory advancements, like the FDA's 2024 SalivaDirect EUA, reduced reagent dependency by 15%. However, a shift to nasal swab-based rapid antigen tests, growing 20% in 2024, restrains saliva-based market growth.
What Challenges and Solutions Exist?
Declining COVID-19 cases, with global vaccinations reaching 70% by 2024, and competition from nasal swab kits, holding a 48.2% share in 2023, challenge market growth. High production costs, averaging US$ 10 per kit, and reagent shortages affect scalability. Solutions include cost-effective rapid tests, like Vatic Health's 2021 CE-marked saliva antigen test, and open-source protocols like SalivaDirect, reducing costs by 20%. Localized production in Asia-Pacific, adopted by 15% of manufacturers, mitigates supply issues. Compliance with WHO and EMA standards ensures market resilience.
Conclusion:
The Global COVID-19 Saliva-Based Detection Kits Market, valued at US$ 1.6 billion in 2021, faces a projected decline to US$ 1.2 billion by 2031 at a -2.8% CAGR. Despite challenges from vaccinations and nasal swab tests, opportunities remain in variant detection and self-testing markets. Stakeholders can leverage Fact.MR's insights to target high-growth regions like Asia-Pacific, invest in innovative diagnostics, and address cost and supply challenges to sustain relevance in this evolving healthcare industry.
Check out More Related Studies Published by Fact.MR Research:
Anti-Sagging Agents Market https://www.factmr.com/report/1959/anti-sagging-agents-market
Negative Photoresist Chemicals Market https://www.factmr.com/report/2029/negative-photoresist-chemicals-market
Anti-Reflective Glass Market https://www.factmr.com/report/2414/anti-reflective-glass-market
CO2 Reforming Catalysts Market https://www.factmr.com/report/2516/co2-reforming-catalysts-market
Hot Insulation Materials Market https://www.factmr.com/report/2521/hot-insulation-materials-market
Surface Modifiers Market https://www.factmr.com/report/2529/surface-modifiers-market
Dewatering Aids Market https://www.factmr.com/report/2984/dewatering-aids-market
Diisobutyl Adipate Market https://www.factmr.com/report/3005/diisobutyl-adipate-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COVID-19 Saliva-Based Detection Kits Market to reach US$ 1.2 Bn by 2031 | Thermo Fisher Scientific Inc; Qiagen; Hologic; Takara Bio In here
News-ID: 4123607 • Views: …
More Releases from Fact.MR
Intracranial Aneurysm Market is Expamding at a CAGR of 10.5% by 2035 |
The global intracranial aneurysm market is poised for robust growth over the next decade, as innovations in treatment techniques and a growing focus on early detection fuel demand. According to the latest market research, the industry is projected to expand at a strong CAGR of 10.5% during the forecast period from 2025 to 2035. This growth trajectory is expected to elevate the market value from USD 1,626 million in 2024…
Airport Kiosk Market to Reach USD 5.67 Billion by 2033 | Avantor, Charter Medica …
The global aviation industry is undergoing a massive transformation as airports increasingly turn to automation and digitalization to enhance passenger experience, reduce operational costs, and improve efficiency. Among the most visible symbols of this shift are airport kiosks, which are now integral to check-in, security, boarding, and baggage handling processes. According to the latest research, worldwide demand for airport kiosks is set to grow at a compound annual growth rate…
Airport Kiosk Market to Reach USD 5.67 Billion by 2033 Driven by Automation in A …
The global aviation industry is undergoing a massive transformation as airports increasingly turn to automation and digitalization to enhance passenger experience, reduce operational costs, and improve efficiency. Among the most visible symbols of this shift are airport kiosks, which are now integral to check-in, security, boarding, and baggage handling processes. According to the latest research, worldwide demand for airport kiosks is set to grow at a compound annual growth rate…
Remote Control Market is Expanding at a CAGR of 4.8% by 2034 | Omni Remote; Zeni …
The global remote control market is on a steady growth trajectory, underpinned by rapid technological advancements and the growing penetration of smart consumer electronics. According to the latest projections by Fact.MR, the market, valued at USD 26.4 billion in 2024, is expected to expand at a CAGR of 4.8% during the forecast period from 2024 to 2034, reaching USD 42.1 billion by the end of 2034. As households and industries…
More Releases for Saliva
Primary Catalyst Driving Artificial Saliva Market Evolution in 2025: Impact of R …
What market dynamics are playing a key role in accelerating the growth of the artificial saliva market?
The increasing incidence of dry mouth syndrome, also known as xerostomia, is projected to fuel the growth of the artificial saliva market. Xerostomia is marked by a continuous sense of dryness in the mouth. The upsurge in this condition has been largely due to the aging demographic, as well as the prevalent use of…
Artificial Saliva Market : An Overview
Introduction:
Artificial saliva is a synthetic product designed to mimic the natural saliva found in the human mouth. It is primarily used to alleviate symptoms associated with xerostomia, or dry mouth, a condition caused by reduced or absent saliva production. Xerostomia is often linked to medical conditions such as Sjögren's syndrome, radiation therapy for head and neck cancer, or side effects from certain medications. Artificial saliva products help to maintain oral…
Artificial Saliva Market
Artificial saliva is a synthetic product designed to replicate the functions of natural saliva in individuals who suffer from conditions that reduce saliva production. Dry mouth, also known as xerostomia, can result from various factors including aging, medication side effects, radiation therapy for cancer, or diseases like Sjögren's syndrome. Natural saliva plays a crucial role in maintaining oral health, aiding in digestion, and protecting the mouth from infections. When the…
Saliva Test Devices Market Scope and Market Size
The measurement of hormones such as cortisol, estrogens, progesterone, and androgens is done using saliva testing, a non-invasive collection technique in which patients collect their saliva in plastic tubes. Because they can gather their sample in the privacy of their home or workplace, this non-invasive saliva collection is perfect for patients.
Full Access Of Report:
https://www.databridgemarketresearch.com/reports/global-saliva-test-devices-market
Top Trending Reports:
https://marketingofreport.wordpress.com/2024/02/02/717/
https://1234submission1234.blogspot.com/2024/02/saliva-test-devices-market-scope-and.html
https://marketingofreport.wordpress.com/2024/02/02/721/
The saliva test devices market is segmented on the basis of type and application. The…
Wearable devices to dominate the Artificial Saliva Market
The Artificial Saliva Market is likely to grow on a robust note in the next decade. The next decade would be seeing the integration of telehealth services with the physical ones that exist at the moment. Urgent care and primary care are bound to be accessed through virtual visits, along with improvement in collaboration with the clinics, dialysis centres, long-term care facilities, and mental health services. This shifting is to…
New HGH Saliva Antigen Covid Test gamechanger
An Austrian company HGH Disinfection und Cosmetique Gmbh, based in 9020 Klagenfurt created with a Korean partner a unique antigen salvia test unit which is so simple that anybody can use it. Till now mass testing was nasal stick by government and doctors. Now this new test unit can be used by everybody without a scarry stick in the nose and a result with 95% is ready in 10…
